Brief: Virpax Pursues OTC Medical Device Pathway For Anqlar™
05/07/2022 14:04
July 5 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PURSUES OTC MEDICAL DEVICE PATHWAY FOR ANQLAR™
Source text for Eikon: ID:nBw1wPXzRa
Further company coverage: VRPX.O
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study